
Verana Health Stock
Verana Health offers a platform for life science innovation that utilizes regulatory-grade specialty data sets
Sign up today and learn more about Verana Health Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Verana Health Stock
Innovation in healthcare is hindered by the time and cost of bringing new therapeutics and devices to market. Verana Health, previously known as DigiSight Technologies, is building a cutting-edge platform for life science innovation that utilizes regulatory-grade specialty data sets. This platform initially utilizes real-world data from the world’s largest clinical database in ophthalmology, representing billions of data points, to deeply understand patient needs and to optimize drug and device development from clinical research through to post-commercialization. To learn more, visit www.veranahealth.com.
Funding History
February 2015 | $7.8M |
---|---|
July 2018 | $30.0M |
Management
Senior Vice President, Technology
Nitin Karandikar
Director
Mark Blumenkranz
Chief Executive Officer
Douglas Foster
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase